NCT01490060: Fosaprepitant in Patients Receiving Ifosfamide-based Regimen |
|
|
| Completed | N/A | 47 | US | Fosaprepitant, Fosaprepitant Dimeglumine, Dexamethasone, Dexamethasone acetate, Decadron, 5HT3 receptor antagonist, Ifosfamide-based chemotherapy (AI), Doxorubicin, Rubex, Adriamycin, Adriamycin RDF, Adriamycin PFS, Doxorubicin Hydrochloride, Mesna, Mesnex, Ifosfamide, Ifex, Vincristine | M.D. Anderson Cancer Center, Merck Sharp & Dohme LLC | Sarcoma, Chemotherapy-induced Nausea and Vomiting, Effects of Chemotherapy, Adverse Effects of Medical Drugs | 03/16 | 03/16 | | |
